New at Fulgent
Fulgent Offers Novel Neutralizing Antibody Detection Assay
This FDA-authorized test detects SARS-CoV-2 neutralizing antibodies, which can indicate long-term immune protection against COVID-19 and offer a more specific target than IgG/IgM-based tests currently on the market. Learn More
Pharmacogenetic (PGx) Testing Now Available
Increase the effectiveness of medications while reducing the risk of adverse drug reactions with PGx testing, available clinically through Fulgent, or at-home through Picture Genetics. Learn More
Complete COVID-19 Solutions Available
Fulgent offers customized end-to-end testing and management solutions for physicians, health agencies, and companies to aid in the detection and prevention of COVID-19. Learn More
Learn More
Learn More
Learn More
Beacon Carrier Screening
Beacon Carrier Screening gives everyone the opportunity to know their carrier risk for severe inherited conditions that are important for family planning and reproductive health. Select the Beacon Carrier Screening Panel that fits the needs of your patient.
LEARN MORE
Parkinson's, Alzheimer's, and Dementia Panels

Updated NGS panels for neurodegenerative disorders:

Parkinson Disease Comprehensive NGS Panel Alzheimer and Dementia NGS Panel Parkinson-Alzheimer-Dementia NGS Panel

CHROMOSOMAL
SEQUENCING ANALYSIS


From CNV to exome: Integrated genetic testing


Discover More
csa banner
Preimplantation Genetic
Testing for Aneuploidy

CLINICIANS

PATIENTS
Cardiovascular
Our cardiovascular panels are divided by presentation of symptoms to better fit your patient needs.


LEARN MORE
Epilepsy
Six featured epilepsy preset panels organized by age of onset, medical actionability, and clinical presentations.


LEARN MORE

FOCUS


focus-icon left-arrow left-arrow

COMPREHENSIVE


comprehensive-icon right-arrow right-arrow
Hereditary Cancer
Focus Cancer
Comprehensive Cancer

Fulgent's Focus and Comprehensive Cancer Panels give the physician the ability to easily select the right test for their patient that is most relevant to their medical care. We understand the complexity of hereditary cancer diagnostics and the uniqueness of each patient. Explore the best option for your patient needs.

New genes added to our preset, focus, and comprehensive panels.

Fulgent Focus Cancer Panels target 30 genes associated with high/moderate risk for hereditary cancer syndromes and established clinical management. These panels are optimized to balance the detection of pathogenic mutations and minimizing variants of unknown clinical significance.

New gene added: GREM1

Fulgent Comprehensive Cancer Panels cover 127 genes associated with potential risk for hereditary cancer syndromes. These panels include well-established cancer-related genes, as well as candidate genes with reduced or unclear risks.

New genes added: CTNNA1, GREM1, NTHL1, SLC45A2

Learn More
Request Specimen Kits

Fulgent offers free specimen collection kits for physicians and genetic counselors within the continental United States.


REQUEST NOW
Quality

Our Lab is CLIA-certified and CAP accredited and surpasses the standards of diagnostic testing. All specimens are processed at our US laboratory. All data analysis is performed on private US server centers.

Test Tracking for Patients About Fulgent CLIA/CAP Laboratory Genes & Panels Known Mutation Test Genomic Testing Hereditary Cancer Tumor Profiling Newborn Genetics Carrier Screening Lab Services Request Specimen Kits